RE:RE:no exogenous insulin supplementation???Go look at the corporate presentation on the website which shows the reduction of insulin. It wasn't very much at all. Echelon report says early, perhaps the pouch starts off reducing but then tapers off or Lowe is out to lunch. Don't get too jazzed folks, there is a reason we are trading where we are....no deal means stagnant share price. No deal also means pharma is not seriously interested. If it was as good as you folks think, you think it'd be hard to make a deal?